Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07287631 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens
A NA study of Hematologic Tests, sponsored by Abbott Point of Care.
- Recruiting
- Registry status
- NA
- Development phase
- 425
- Enrollment target
- 3
- Study locations
NCT07287631: Recruiting NA study of Hematologic Tests, sponsored by Abbott Point of Care.
NCT07287631 is a NA study of Hematologic Tests that is actively recruiting participants, run by Abbott Point of Care. The registered enrollment target is 425 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07287631, a NA study of Hematologic Tests, is actively recruiting participants, sponsored by Abbott Point of Care.
- RECRUITING
- Registry status
- NA
- Development phase
- 425 participants
- Enrollment target
- 3
- Study locations
Study Summary
Assess precision of the i-STAT potassium (K) and ionized calcium (iCa) tests using i-STAT CG8+ cartridge on the i-STAT 1 analyzer.
Primary Outcome
Assess the precision of the i-STAT potassium (K) and ionized calcium (iCa) tests in mmol/L with the investigational use only (IUO) i-STAT CG8+ cartridge on the i-STAT 1 analyzer using results from capillary specimens from each subject enrolled in the study.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Capillary blood draw
Study Locations (3)
New Mexico
- University of New Mexico - Albuquerque
Pennsylvania
- Penn State Health Milton S. Hershey Medical Center (Hershey) - Hershey
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 425 participants |
| Start Date | 2025-09-17 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT07287631 shows while recruiting
NCT07287631 is an interventional study that assigns participants to a tested intervention. The registered 425 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Hematologic Tests appearing as the primary indexed condition, and to 1 intervention - of which Capillary blood draw is the first listed.
NCT07287631 reports a single indexed study location in New Mexico, Pennsylvania, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07287631 about?
NCT07287631 is a clinical study titled "Clinical Evaluation of Precision for the Potassium and Ionized Calcium Tests in Capillary Specimens". Assess precision of the i-STAT potassium (K) and ionized calcium (iCa) tests using i-STAT CG8+ cartridge on the i-STAT 1 analyzer.
What is the current status of trial NCT07287631?
This trial is currently recruiting. It is a NA study. The enrollment target is 425 participants. The study started on 2025-09-17. Estimated completion is 2026-12.
What conditions does trial NCT07287631 study?
This clinical trial studies the following conditions: Hematologic Tests.
What interventions are being tested in trial NCT07287631?
The interventions under investigation include: Capillary blood draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07287631?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07287631 being conducted?
This trial has 3 study locations across New Mexico, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Tests
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07287631's enrollment target sits among peer trials
425 236th of 2000 higher than 1,763 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04265430 · 425 participants · Phase 4
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
- NCT04278690 · 425 participants · NA
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
- NCT05321368 · 425 participants · NA
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
- NCT05340738 · 425 participants · NA
AI-Based Fidelity Feedback to Enhance CBT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI